**Lathosterolosis: A Rare Cholesterol Biosynthesis Disorder with Clinical and Genetic Insights**

Lathosterolosis is a rare autosomal recessive disorder caused by mutations in the sterol-C5-desaturase-like (SC5DL) gene located on chromosome 11q23. This genetic defect leads to deficiency of the enzyme 3-beta-hydroxysteroid-delta-5-desaturase, which plays a critical role in cholesterol biosynthesis by catalyzing the conversion of lathosterol into 7-dehydrocholesterol. The resulting metabolic block causes significant accumulation of lathosterol and other sterol intermediates, disrupting normal cellular function. Although first described in 2002, only three cases have been reported in the literature prior to this case report, with limited clinical data available. We present a fourth documented case of lathosterolosis in a young child who exhibited dysmorphic features, multiple congenital anomalies, and global developmental delay—clinical signs that initially raised suspicion for Smith-Lemli-Opitz syndrome (SLOS), a more commonly recognized cholesterol synthesis disorder.

The patient, a male infant born at term to non-consanguineous Caucasian parents, was noted at birth to have bitemporal narrowing, a broad nasal tip without anteverted nostrils, micrognathia, microcephaly, bilateral postaxial hexadactyly of the feet, and soft tissue syndactyly between the second and third toes. Developmental milestones were significantly delayed, with a Griffiths Mental Developmental Scale assessment at 20 months revealing a mental age of just 11 months. Brain MRI at 18 months was unremarkable. Initial diagnostic consideration focused on SLOS due to overlapping phenotypic features, but plasma sterol analysis revealed markedly elevated lathosterol levels (81.TNNT2 Antibody Formula 6 mmol/L; normal <18 mmol/L), while 7-dehydrocholesterol and cholesterol remained within normal limits. This distinct sterol profile prompted further investigation. Skin fibroblasts from the patient confirmed the diagnosis, showing increased lathosterol content (1.48% of total sterols) and elevated 8,9-cholestenol (17.53%). Filipin staining demonstrated abnormal intracellular cholesterol distribution, consistent with impaired sterol metabolism. Genetic testing identified two novel compound heterozygous missense mutations in the SC5DL gene: p.K148E in the mother and p.D210E in the father. Bioinformatics analysis predicted these variants to be damaging to protein function. The patient began treatment with simvastatin at 0.2 mg/kg/day, gradually increased to 1 mg/kg/day. Within four weeks, plasma lathosterol levels normalized (from 81.6 to 7.2 mmol/L), and no adverse effects were observed. Creatine kinase and liver function tests remained stable throughout follow-up. Developmental assessment at 45 months showed improvement, with overall mental age increasing to 29 months and developmental quotient rising from 55 to 64. Notably, practical reasoning scores reached the low normal range. Serial imaging revealed mild, nonprogressive hepatic changes suggestive of early parenchymal disease, though liver function remained intact. Bilateral small dot cataracts were detected at age 4, which also appeared in the father, suggesting possible hereditary involvement.N-Fmoc-8-aminooctanoic acid Description Despite the rarity of the condition, this case highlights the importance of full sterol profiling—even when cholesterol and 7-dehydrocholesterol are normal—in patients with dysmorphic features and developmental delay.PMID:35047419

Simvastatin therapy appears effective in reducing toxic sterol accumulation and may contribute to neurodevelopmental stabilization. However, long-term outcomes remain uncertain. Additional cases are essential to clarify genotype-phenotype correlations and assess the durability and safety of statin-based intervention. Lathosterolosis remains a challenging diagnosis, often mistaken for SLOS, but its recognition underscores the need for comprehensive metabolic evaluation in children with congenital malformations and intellectual disability.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com